Genetic variants that cause rare disorders may remain elusive even after expansive testing, such as exome sequencing. The diagnostic yield of genome sequencing, particularly after a negative ...
One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid increases in genetic technology and testing. Even when a person does have ...
Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...
Whole genome sequencing (WGS) is not necessarily a solution for someone with a rare, monogenic disease. Indeed, more than half of families with suspected rare monogenic diseases do not have an answer ...
Advances in DNA sequencing technology help forensic biologists identify suspects where traditional DNA profiling has failed, ...
Clinical genome sequencing now delivers genetic diagnoses for about 1 in 4 suspected rare disease patients, guiding targeted care and shaping newborn screening worldwide.
MIAMI (EMBARGOED UNTIL APRIL 8, 2026, AT 5AM EDT – 10AM LONDON TIME) – A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic ...
Morning Overview on MSN
New protein method generates 10M data points in 3 days, boosting AI models
A team at Rice University has built a lab platform that can map the activity of more than 10 million protein variants in a ...
A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to diagnosis from years to days -- in a single test and at a much lower cost. One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results